US Patent

US10398785 — Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use

Formulation · Assigned to Meridian Lab · Expires 2036-03-14 · 10y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical formulations for parenteral administration that combine taxane compounds with cyclodextrins and polyethylene glycol.

USPTO Abstract

Pharmaceutical formulations for parenteral administration comprising taxane compounds complexed with cyclodextrins and polyethylene glycol, methods of making the pharmaceutical formulations and methods of treating cancer patients using the pharmaceutical formulations.

Drugs covered by this patent

Patent Metadata

Patent number
US10398785
Jurisdiction
US
Classification
Formulation
Expires
2036-03-14
Drug substance claim
No
Drug product claim
Yes
Assignee
Meridian Lab
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.